ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.
Ticker SymbolZIMV
Company nameZimVie Inc
IPO dateFeb 14, 2022
CEOMr. Vafa Jamali
Number of employees1770
Security typeOrdinary Share
Fiscal year-endFeb 14
Address4555 Riverside Drive
CityPALM BEACH GARDENS
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code33410
Phone18003425454
Websitehttps://www.zimvie.com/en
Ticker SymbolZIMV
IPO dateFeb 14, 2022
CEOMr. Vafa Jamali
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data